Cardio-Adipose Tissue Cross-Talk: Relationship Between Adiponectin, Plasma Pro Brain Natriuretic Peptide and Incident Heart Failure
Open Access
- 10 April 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 16 (6) , 633-638
Abstract
Aims There is increasing evidence of cross-talk between the heart, body metabolism, and adipose tissue, but the precise mechanisms are poorly understood. Natriuretic peptides (NPs) have recently emerged as the prime candidate for a mediator. In patients with heart failure (HF), infusion of NPs increases adiponectin secretion, indicating that NPs may improve adipose tissue function and in this way function as a cardio-protective agent in HF. Accordingly we investigated the interplay between plasma adiponectin, plasma proBNP, and development of HF. Methods and results We prospectively followed 5574 randomly selected men and women from the community without ischaemic heart disease or HF. Plasma adiponectin and proBNP were measured at study entry. Median follow-up time was 8.5 years (interquartile range 8.0–9.1 years). During follow-up 271 participants developed symptomatic HF. Plasma adiponectin and proBNP were strongly associated (P < 0.001). Participants with increasing adiponectin had increased risk of incident HF (P < 0.001). After adjustment for confounding risk factors (including age, gender, smoking status, body mass ratio, waist–hip ratio, glucose, glycated haemoglobin, systolic and diastolic blood pressure, lipid profile, high sensitivity C-reactive protein, estimated glomerular filtration rate, and physical activity) by Cox regression analysis, adiponectin remained an independent predictor of HF: the hazard ratio (HR) per 1 standard deviation (SD) increase in adiponectin was 1.20 [95% confidence interval (CI) 1.06–1.30; P = 0.003]. However, the association vanished when plasma proBNP was included in the analysis, HR 1.08 (95% CI 0.95–1.23; P = 0.26). Conclusions In conclusion, plasma adiponectin and proBNP are strongly associated. Increasing plasma adiponectin is associated with increased risk of HF. However, concomitantly elevated proBNP levels appear to explain the positive association between adiponectin and risk of HF.Keywords
This publication has 33 references indexed in Scilit:
- Natriuretic peptides enhance the oxidative capacity of human skeletal muscleJournal of Clinical Investigation, 2012
- Atrial Natriuretic Peptide and Adiponectin Interactions in ManPLOS ONE, 2012
- Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytesJournal of Clinical Investigation, 2012
- Beta-blockers modify the prognostic value of adiponectin in chronic heart failureInternational Journal of Cardiology, 2011
- Atrial natriuretic peptide regulates lipid mobilization and oxygen consumption in human adipocytes by activating AMPKBiochemical and Biophysical Research Communications, 2011
- High plasma adiponectin is related to low functional capacity in patients with chronic heart failureInternational Journal of Cardiology, 2010
- A New Role for the Natriuretic PeptidesJACC, 2009
- Relation of Adiponectin and High-Sensitivity C-Reactive Protein to Pulse-Wave Velocity and N-Terminal Pro-B-Type Natriuretic Peptide in the General PopulationThe American Journal of Cardiology, 2009
- Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndromeJournal of Clinical Investigation, 2006
- Dual ACE/NEP inhibitors – more than playing the ACE cardJournal of Human Hypertension, 2006